Regulus Therapeutics | Cassa E Equivalenti

Cash And Equivalent Cambiamento Data
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Celldex Therapeutics USD 34.81M 13.68M 2023-12
Clal Biotechnology ILS 7.44M 734K 2022-12
Compugen USD 47.78M 30.71M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Grifols EUR 484.23M 39.13M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Takeda JPY 318.05B 1.67B 2023-09



Regulus Therapeutics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.